Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in Egyptian Patients With COVID-19

NCT05679414 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05679414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in Egyptian Patients With COVID-19
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
May 11, 2022
Completion date
November 30, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19 associated coagulopathy